Cargando…
Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective
Several biologic treatments are available in addition to intravenous also in subcutaneous form for treatment of chronic diseases. Benefits of the subcutaneous application of drugs include self-administration by the patient, shorter time of application process with less infusion related adverse event...
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654488/ https://www.ncbi.nlm.nih.gov/pubmed/34879868 http://dx.doi.org/10.1186/s12919-021-00230-7 |